Information Disclosure
Referring to Financial Service Authority (“OJK”) Regulation No. 31/POJK.04/2015 on Information Disclosure of Material Facts by Issuer of Public Company, we, PT Pyridam Farma Tbk (“Company”) hereby inform that the Company and its affiliate intends to (i) purchase 27,385 shares
Public Expose Announcement
PUBLIC EXPOSE ANNOUNCEMENT PT PYRIDAM FARMA TBK The Board Directors of PT Pyridam Farma Tbk., domiciled in South Jakarta (hereinafter referred to as the “Company”) hereby invites the shareholders to attend the Electronic Public Expose (“Public Expose”) of the company which will
Report of Fund Utilization – Obligasi Pyridam Farma I 2020 – Juni 2021
Click link below: Report of Fund Utilization - Obligasi Pyridam Farma I 2020-Juni 2021
The Increase of PT Bank OCBC NISP Tbk’s Loan Facility
Referring to Financial Service Authority (“OJK”) Regulation No. 17/POJK.04/2020 on Material Transaction and Business Activity Changes (“POJK No. 17/2020”), OJK Regulation No. 31/POJK.04/2015 on Disclosure of Information or Material Facts by Issuers or Public Companies and Indonesia Stock Exchange Regulation
The Completion of the Subscription of New Shares in the Fullerton Health Indonesia Group by PT Pyfa Investama Medika
Referring to Financial Service Authority (“OJK”) Regulation No. 31/POJK.04/2015 on Information Disclosure of Material Facts by Issuer of Public Company, we, PT Pyridam Farma Tbk. (“Company”) hereby inform: Company is the 99.00% shareholder from the total issued and paid-up capital of
PT Pyridam Farma Tbk. Enters into A Cooperation Agreement with LG International Corp.
Referring to Financial Service Authority (“OJK”) Regulation No. 31/POJK.04/2015 on Information Disclosure of Material Facts by Issuer of Public Company, we, PT Pyridam Farma Tbk. (“Company”) hereby inform that the Company intends to cooperate with LG International Corp. (“LGI”), a
Signing of Four Shares Subscription Agreements by PT Pyfa Investama Medika to Subscribe New Shares in the Fullerton Health Indonesia Group
Referring to Financial Service Authority (“OJK”) Regulation No. 31/POJK.04/2015 on Information Disclosure of Material Facts by Issuer of Public Company, we, PT Pyridam Farma Tbk. (“Company”) hereby inform that the Company is the 99.00% shareholder from the total issued and
Establishment of Four Subsidiaries in Indonesia
Referring to Financial Service Authority (“OJK”) Regulation No. 31/POJK.04/2015 on Information Disclosure of Material Facts by Issuer of Public Company and the Decision of the Board of Directors of the Indonesia No. Kep. 00015/BEI/01-2021 on the Amendment of Regulation No.
The Opening of Representation Office in South Korea
Referring to Financial Service Authority (OJK) Regulation No. 31/POJK.04/2015 on Information Disclosure of Material Facts by Issuer of Public Company and the Decision of the Board of Directors of the Indonesia No. 00015/BEI/01-2021 on the Amendment of Regulation No. I-E
Prospectus of Public Offering of Pyridam Farma Bond I 2020
Prospectus of Pyridam Farma Bond I 2020